CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

CRISPR Therapeutics has rallied on Casgevy progress, but overvaluation, early-stage pipeline, and lack of profits raise ...

For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without ...

Therapies based on this technology are likely to have a reduced risk of unintended negative effects compared to first or second generation CRISPR,” she says. In a few years – once testing in animals ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Mars, maker of M&M's and Skittles, is turning to CRISPR gene editing to develop more resilient cacao plants, with the aim of strengthening cocoa production by tackling agricultural challenges. The ...